Neuphoria Therapeutics Inc. (NEUP) Operating income 2023–2026
Neuphoria Therapeutics Inc. (NEUP) annual operating income history from SEC filings — each fiscal year as reported.
-$16.5MFY2026 · since FY2023: -$22.0M → -$16.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -$16.5M | -1357.0% |
| FY2025 | -$1.1M | +93.7% |
| FY2024 | -$17.9M | +18.6% |
| FY2023 | -$22.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More NEUP financial trends
NEUP RevenueNEUP Net incomeNEUP Net marginNEUP Gross profitNEUP Gross marginNEUP Operating marginNEUP Operating cash flowNEUP Free cash flowNEUP Capital expendituresNEUP Return on equityNEUP Stock buybacksNEUP Dividends paidNEUP Total assetsNEUP Total liabilitiesNEUP Shareholders’ equityNEUP overview →